Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Mogakane, R.T.![]() |
|
dc.contributor.author | Abdool, Zeelha![]() |
|
dc.contributor.author | Ahmad, Samia![]() |
|
dc.contributor.author | Swanepoel, H.M.![]() |
|
dc.date.accessioned | 2018-04-19T07:07:39Z | |
dc.date.available | 2018-04-19T07:07:39Z | |
dc.date.issued | 2017-12 | |
dc.description.abstract | BACKGROUND : Symptomatic uterine fibroids have a significant impact on women’s health. Surgical intervention (myomectomy and hysterectomy) has been the mainstay of treatment. Women living with symptomatic uterine fibroids contribute significantly to a growing waiting list for surgery in South African public hospitals. Uterine artery embolisation (UAE) is a newer treatment option and has shown to be a minimally invasive, safe and effective alternative to surgery for such women. OBJECTIVE : To evaluate the efficacy of UAE in women with symptomatic fibroid uterus. METHODS : A prospective, observational, single-centre study of 51 women with symptomatic fibroid uterus who underwent UAE at Steve Biko Academic Hospital from February 2007 to November 2012. RESULTS : A total of 51 women underwent UAE, 3 of whom were lost to follow-up. The remaining 48 women were followed for a mean duration of 43.6 months. There was a statistically significant reduction in the mean uterine and dominant myoma volumes, as well as improvement in the haemoglobin levels (p=0.001). The mean uterine and dominant fibroid volume reductions were 38% and 58%, respectively. Minor complications were reported in 19% of the women (fever, post-embolisation syndrome and vaginal fibroid passage were frequently reported complications). Reintervention (hysterectomy and gonadotropin-releasing hormone analogue use) was required in 35% of women. CONCLUSION : UAE has a good clinical effect on fibroid volume reduction. It is a treatment option that can be considered prior to major surgery in a select group of women with symptomatic fibroid uterus. | en_ZA |
dc.description.department | Obstetrics and Gynaecology | en_ZA |
dc.description.department | Radiology | en_ZA |
dc.description.librarian | am2018 | en_ZA |
dc.description.uri | http://sajog.org.za/index.php/SAJOG | en_ZA |
dc.description.uri | http://www.journals.co.za/content/journal/m_sajog | en_ZA |
dc.identifier.citation | Mogakane, R.T., Abdool, Z., Ahmad, S. et al. 2017, 'The impact of uterine artery embolisation on fibroid volume at 43.6 months in women with symptomatic fibroids at a tertiary-level hospital', South African Journal of Obstetrics and Gynaecology, vol. 23, no. 3, pp. 97-100. | en_ZA |
dc.identifier.issn | 0038-2329 (print) | |
dc.identifier.issn | 2078-5135 (online) | |
dc.identifier.other | 10.7196/SAJOG.2017.v23i3.1228 | |
dc.identifier.uri | http://hdl.handle.net/2263/64606 | |
dc.language.iso | en | en_ZA |
dc.publisher | Health and Medical Publishing Group | en_ZA |
dc.rights | © 2018, South African Medical Association. All rights reserved. This article is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0) . | en_ZA |
dc.subject | Symptomatic uterine fibroids | en_ZA |
dc.subject | Women | en_ZA |
dc.subject | Surgery | en_ZA |
dc.subject | South African public hospitals | en_ZA |
dc.subject | Uterine artery embolisation (UAE) | en_ZA |
dc.title | The impact of uterine artery embolisation on fibroid volume at 43.6 months in women with symptomatic fibroids at a tertiary-level hospital | en_ZA |
dc.type | Article | en_ZA |